Trials / Terminated
TerminatedNCT00051688
Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Chiron Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate tumor response to the combination of anti-cancer drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tezacitabine | |
| DRUG | oxaliplatin |
Timeline
- Start date
- 2003-06-01
- Completion
- 2004-08-01
- First posted
- 2003-01-16
- Last updated
- 2006-07-11
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00051688. Inclusion in this directory is not an endorsement.